How Long Does Spravato Take to Work? A Week-by-Week Timeline

If you are about to start Spravato (esketamine) for depression that has not improved on other treatments, the question on your mind is almost always the same: how long until I feel better? The honest answer is that Spravato works far faster than a traditional antidepressant — some people notice a shift within 24 hours of their first dose — but a fast first response is not the whole story.

For most patients who respond, meaningful relief builds gradually over the first four-week induction phase — eight supervised sessions — and the full benefit is usually clearer by weeks four to six. Some feel early changes in sleep, energy, or the heaviness of their mood within the first week or two; others need the full induction course before the change is obvious. Below is a realistic timeline of what to expect, and what shapes how quickly you get there.

How Fast Does Spravato Work? The Short Answer

Standard oral antidepressants — SSRIs and SNRIs — typically take four to six weeks to produce a noticeable effect. That delay is one of the hardest parts of treating depression, especially when someone is in crisis. Spravato is different. In controlled clinical trials, some patients improved within 24 hours of the first dose, and a measurable separation from placebo was often visible within that first day.

That speed is exactly why esketamine was also approved for major depressive disorder with acute suicidal ideation — when waiting weeks is not safe. But “starts working within 24 hours” and “fully better in 24 hours” are not the same thing. The early lift is real, and it still has to be consolidated over a structured course of treatment. Think of the first dose as the beginning of the curve, not the destination.

The Spravato Timeline: What to Expect, Hour by Hour and Week by Week

Everyone’s response is individual, but the research and clinical experience point to a fairly consistent pattern. Here is the timeline most patients can expect.

• First few hours to 24 hours: Esketamine reaches peak levels in the body within about 20 to 40 minutes, and some people — particularly those with severe or suicidal depression — notice an early shift within the first day: more mental clarity, a lifting of dark thoughts, or simply feeling lighter. Others feel nothing yet beyond the temporary in-session effects, which is completely normal.
• Days 1 to 3 (after the first dose): Any early benefit from the first session tends to be temporary at this stage — a single dose can ease symptoms for up to about 24 hours. This is why the schedule front-loads treatment with two sessions a week rather than one.
• Weeks 1 to 2 (sessions 2 to 4): Subtle, more consistent improvements often start to appear — better sleep, slightly more energy, or feeling “less bad” rather than dramatically better. These early signs are meaningful and worth tracking, even when they feel small.
• Weeks 3 to 4 (completing induction): By the end of the four-week induction phase, most patients who are going to respond see a substantial reduction in depressive symptoms. This is the point at which your psychiatrist can tell, with reasonable confidence, whether Spravato is working for you.
• Week 5 and beyond (maintenance): As dosing tapers to once a week or every other week, responders typically settle into steadier, more normalized mood, better motivation, and more engagement in daily life. For many, the full benefit becomes most apparent during these first weeks of maintenance.

If you respond well, most of the heavy lifting happens in that first month. If you are a slower responder, the maintenance phase is where the gains often consolidate — which is one of several reasons not to judge the treatment by the first session or two.

Why Spravato Works Faster Than Traditional Antidepressants

The speed comes down to how the medication acts on the brain. Traditional antidepressants work on the serotonin, norepinephrine, and dopamine systems, and they have to build up gradually before downstream changes take hold — hence the multi-week wait. Spravato works on a different pathway entirely: the glutamate system, the brain’s primary excitatory signaling network.

Esketamine blocks NMDA receptors, which triggers a surge of glutamate and sets off a cascade that increases brain-derived neurotrophic factor (BDNF) and promotes the growth of new synaptic connections — a process called neuroplasticity. In plain terms, it helps the brain rebuild connections in mood-regulating circuits that depression tends to weaken. That mechanism is why the effect can appear quickly and why, with repeated dosing, the benefit can outlast the drug itself. We break down the difference in more detail in our guide to how Spravato differs from traditional antidepressants.

The Treatment Schedule Behind the Timeline

The timeline above maps directly onto a standard treatment schedule, which has two phases:

• Induction phase (weeks 1 to 4): Spravato is given twice a week — eight sessions total — to jump-start improvement. Each dose is self-administered as a nasal spray in the clinic, under medical supervision.
• Maintenance phase (week 5 onward): If you respond, treatment usually tapers to once weekly for about a month, then to once weekly or every other week, at the lowest frequency that keeps you well.

One important detail: Spravato is almost always prescribed alongside a new or continuing oral antidepressant, not on its own. The two work together, and skipping sessions during induction is one of the most common reasons people see a slower or weaker response. Consistency in that first month genuinely matters. You can see the full structure of how we deliver treatment on our Spravato (esketamine) treatment page, and the monitoring rules are explained in our overview of the Spravato REMS program.

How to Tell If Spravato Is Working

Because depression lifts gradually and unevenly, the early signs are easy to miss if you are waiting for a single dramatic moment. More often, improvement shows up first in the background details of daily life:

• Sleeping better, or waking less often
• A little more energy or motivation to do ordinary tasks
• The emotional “heaviness” easing, or dark thoughts feeling less constant
• Reconnecting with people or activities you had withdrawn from

This is also why good clinics practice measurement-based care — tracking standardized scores like the PHQ-9 or MADRS at each visit. A questionnaire can catch a real but gentle improvement that you might otherwise dismiss, and it gives your psychiatrist objective data to decide whether to continue, adjust, or change course. If you want the bigger picture on how often esketamine produces meaningful results, our deep dive on the Spravato success rate covers the response and remission numbers honestly.

What the First Day — and the Day After — Feel Like

During and shortly after a session, Spravato commonly causes temporary effects: a floaty or dreamlike sensation, mild dissociation (feeling detached from your body or surroundings), lightheadedness, or drowsiness. These usually peak within the first hour and fade over the two-hour in-clinic monitoring period that follows every dose. Because of the sedation and dissociation, you cannot drive yourself home that day — you will need a ride and should rest for the remainder of the day.

The day after is usually different. Most people feel back to normal physically, and some describe feeling clearer or lighter — a calm or “reset” sensation that follows a good session. Many patients find the experience itself calming or introspective rather than unpleasant. If you want to know exactly what sensations are typical and how they are managed, see our detailed guide to Spravato side effects and how to manage them.

Factors That Affect How Quickly Spravato Works

How fast you respond depends on more than the medication. Several factors shift the timeline, and a few are within your control:

• Severity of depression. More severe symptoms can take longer to shift meaningfully, even when an early response is present.
• Treatment history. People who have tried many medications without success may have a more gradual response — though that same group is also where Spravato is most valuable.
• Consistency of sessions. Completing all eight induction sessions on schedule is strongly associated with better and faster response. Missed sessions slow momentum.
• Overall health and lifestyle. Sleep, nutrition, stress, and physical health all influence how the brain responds to treatment.
• The rest of your plan. Pairing Spravato with the right oral antidepressant, therapy, and support tends to produce stronger, more durable results than the medication alone.

What If Spravato Isn’t Working Yet?

If you are a week or two in and not feeling much, that does not mean Spravato has failed. The single most common mistake is judging the treatment too early. The fair test is the full four-week induction course — eight sessions — because that is the window the clinical trials used to measure response. Many people who feel little after two or three sessions improve substantially by the end of the month.

That said, Spravato does not help everyone, and an honest plan accounts for that. If you complete induction without a meaningful response, your psychiatrist may adjust the dose, revisit the oral antidepressant, or discuss other advanced options for depression that is not improving — including TMS, intramuscular ketamine, or a combination approach. If you are not yet sure whether you even fit the treatment-resistant picture, our guide on how to know if you have treatment-resistant depression is a good place to start.

How Long Does Spravato Stay in Your System?

This is a frequent and reasonable question, because Spravato’s lasting effect can seem at odds with how briefly the drug is actually present. Esketamine clears the body quickly — it has an elimination half-life of roughly 7 to 12 hours, so the medication itself is largely gone within a day or so of a dose. The in-session effects wear off within a couple of hours.

The benefit lasts much longer than the drug because Spravato’s antidepressant effect comes from the neuroplastic changes it sets in motion, not from a steady drug level in your blood. That is the whole point of the schedule: repeated, spaced-out doses reinforce those circuit changes so the improvement holds even though each individual dose leaves your system quickly.

Spravato at Bright Horizons Psychiatry in Maryland

At Bright Horizons Psychiatry in Rockville, MD — and now in Frederick — we are a REMS-certified Spravato provider focused on the kind of complex, treatment-resistant depression where esketamine does its best work. We practice measurement-based care, tracking your symptoms at every visit so we can tell early whether Spravato is working and adjust your plan when it is not. That is often the difference between a slow, uncertain start and a clear, well-supported response.

How quickly Spravato works for you depends on your history, your diagnosis, and your whole treatment plan — none of which a timeline on a webpage can fully predict. The next step is a real evaluation with a psychiatrist who can give you a candid read on what to expect.

Frequently Asked Questions

Medical disclaimer: This article is for general educational purposes and is not medical advice. Timelines are based on published research and typical clinical experience and may not reflect your individual results. Always consult a qualified psychiatrist about your specific situation before making treatment decisions.

Key sources: U.S. FDA SPRAVATO prescribing information; Janssen/Johnson & Johnson SPRAVATO medical content; National Alliance on Mental Illness (NAMI), Esketamine (Spravato); Popova et al., TRANSFORM-2 (American Journal of Psychiatry, 2019); Daly et al., SUSTAIN-1 (JAMA Psychiatry, 2019); long-term maintenance analyses of esketamine for treatment-resistant depression.